Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 9—September 2024
Research

Effects of Rotavirus Vaccination Coverage among Infants on Hospital Admission for Gastroenteritis across All Age Groups, Japan, 2011–2019

Kenji Kishimoto, Susumu Kunisawa, Kiyohide Fushimi, and Yuichi ImanakaComments to Author 
Author affiliations: Graduate School of Medicine, Kyoto University, Kyoto, Japan (K. Kishimoto, S. Kunisawa, Y. Imanaka); Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan (K. Fushimi); Centre for Health Security, Graduate School of Medicine, Kyoto University, Kyoto (Y. Imanaka)

Main Article

Figure 1

Time trends in gastroenteritis hospitalizations among different study populations in study of effects of rotavirus vaccination coverage among infants on hospital admission for gastroenteritis across all age groups, Japan, 2011–2019. A) Monthly numbers of gastroenteritis inpatients in the overall population, compared with annual mean rotavirus vaccination coverage. B–F) Monthly numbers of gastroenteritis hospitalizations among different study populations: B) young children <5 years of age; C) older children and adolescents 5–19 years of age; D) adults 20–59 years of age; E) older adults ≥60 years of age; F) immunocompromised persons.

Figure 1. Time trends in gastroenteritis hospitalizations among different study populations in study of effects of rotavirus vaccination coverage among infants on hospital admission for gastroenteritis across all age groups, Japan, 2011–2019. A) Monthly numbers of gastroenteritis inpatients in the overall population, compared with annual mean rotavirus vaccination coverage. B–F) Monthly numbers of gastroenteritis hospitalizations among different study populations: B) young children <5 years of age; C) older children and adolescents 5–19 years of age; D) adults 20–59 years of age; E) older adults ≥60 years of age; F) immunocompromised persons.

Main Article

Page created: July 31, 2024
Page updated: August 13, 2024
Page reviewed: August 13, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external